TransMedics Group (TMDX) Financials

$86.40

$-1.87 (-2.12%)

As on 09-Sep-2026 16:12EDT

Market cap

$3,120 Mln

Revenue (TTM)

$668 Mln

P/E Ratio

23.3

P/B Ratio

5.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	668.47	605.49	441.54	241.62	93.46	30.26
Cost of Revenue	276.12	242.69	179.46	87.53	28.19	9.10
Gross Profit	392.35	362.81	262.08	154.09	65.27	21.16
Operating Expenses	310.74	254.22	224.59	182.82	96.71	60.59
Operating Profit (EBIT)	81.61	108.58	37.50	-28.73	-31.44	-39.43
Other Income	--	--	--	--	--	-0.88
Profit before Tax	72.55	107.52	35.78	-26.67	-36.17	-44.18
Provision for Tax	-79.15	-82.77	0.32	-1.64	0.07	0.04
Profit after Tax (Net Income)	151.70	190.29	35.46	-25.03	-36.23	-44.22
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-36.23	-44.22

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	518.05	473.10	228.60	137.20	187.38	67.85
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	848.06	505.97	515.56	513.91	66.11	43.80
Current Liabilities	98.28	89.31	59.91	54.93	23.66	23.24
Total Liabilities	1,562.68	1,068.37	804.08	706.05	277.15	134.89

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	813.27	430.59	306.86	195.39	24.85	16.19
Current Assets	651.12	637.78	497.22	510.65	252.29	118.71
Total Assets	1,562.68	1,068.37	804.08	706.05	277.15	134.89
Total Debt*	867.72	469.69	518.29	515.95	67.56	43.80
Net Current Assets	552.84	548.48	437.30	455.72	228.63	95.47

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	192.84	48.80	-13.03	-45.82	-28.86
Cash Flow from Investing Activities	--	-59.25	-129.30	-193.95	54.51	29.27
Cash from Financing Activities	--	16.86	22.87	400.42	167.93	1.39
Net Cash Inflow / Outflow	--	--	--	--	--	1.80

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	3.73	4.65	1.01	-0.73	-1.13	-1.59
Cash EPS ($)	--	5.31	1.57	-0.56	-1.02	-1.53
Adjusted Book Value ($)	--	11.56	6.49	4.01	5.85	2.44
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	4.71	1.39	-0.38	-1.43	-1.04
Free Cash Flow per Share ($)	--	3.26	-2.30	-5.62	-1.80	-1.17

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	22.52	5.07	-5.51	-19.77	-35.34
ROE (%)	30.61	54.24	19.39	-15.42	-28.39	-51.49
ROA (%)	12.09	20.33	4.70	-5.09	-17.59	-30.82
EBIT Margin (%)	10.05	20.03	11.37	-6.57	-34.71	-133.19
Net Margin (%)	22.69	31.43	8.03	-10.36	-38.77	-150.47
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	25.82	0.37	0.83	1.59	2.09	0.18
EBIT Growth (%)	-23.87	141.69	416.05	51.05	19.52	-62.97
Net Profit Growth (%)	111.69	436.58	241.70	30.92	18.06	-53.80
EPS Growth (%)	105.53	3.62	2.38	0.35	0.29	-0.50
Book Value Growth (%)	62.26	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	23.31	26.16	61.91	-107.79	-54.53	-12.03
Price / Book Value	5.82	10.52	9.60	19.66	10.54	7.84
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	24.93	33.40	33.98	-365.95	-63.61	-12.56
Close Price ($)	66.42	121.65	62.35	78.93	61.72	19.16
High Price ($)	156.00	156.00	177.37	99.63	64.36	49.50
Low Price ($)	60.11	55.00	58.27	36.42	10.00	17.20
Market Cap ($ Cr)	3,120.07	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.95	0.99	2.27	3.76	0.36	0.65
Short term debt to equity ratio	0.05	0.03	0.01	0.01	0.01	0.13
Current Ratio	6.62	7.14	8.30	9.30	10.66	5.11
Quick Ratio	6.07	6.59	7.52	8.49	9.79	4.47
Interest Coverage	4.42	8.80	3.48	-1.47	-8.71	-10.40

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	15.58	13.92	22.13	26.31	29.54	19.61
Asset Turnover	0.53	0.65	0.58	0.49	0.45	0.21
Receivable days	--	54.89	66.71	68.92	65.55	77.23
Inventory Days	--	71.82	92.39	135.28	229.77	537.52
Payable days	--	15.53	23.41	33.50	64.74	157.63
Cash Conversion Cycle	--	111.18	135.69	170.70	230.58	457.13

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.